These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19931226)

  • 1. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
    Zagon IS; Rahn KA; Bonneau RH; Turel AP; McLaughlin PJ
    Brain Res; 2010 Jan; 1310():154-61. PubMed ID: 19931226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
    Rahn KA; McLaughlin PJ; Zagon IS
    Brain Res; 2011 Mar; 1381():243-53. PubMed ID: 21256121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
    Campbell AM; Zagon IS; McLaughlin PJ
    Brain Res; 2012 Sep; 1472():138-48. PubMed ID: 22820301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
    Zagon IS; Rahn KA; Turel AP; McLaughlin PJ
    Exp Biol Med (Maywood); 2009 Nov; 234(11):1383-92. PubMed ID: 19855075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
    Campbell AM; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Jan; 90():43-51. PubMed ID: 22985690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
    Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
    Immunobiology; 2011 May; 216(5):579-90. PubMed ID: 20965606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
    Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
    Immunobiology; 2011; 216(1-2):173-83. PubMed ID: 20598772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum [Met
    Ludwig MD; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2017 Sep; 134():1-9. PubMed ID: 28647454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ; McHugh DP; Magister MJ; Zagon IS
    BMC Immunol; 2015 Apr; 16():24. PubMed ID: 25906771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Truong JJ; Kerr BJ
    Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Ludwig MD; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
    Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA
    J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis.
    Pifarre P; Prado J; Baltrons MA; Giralt M; Gabarro P; Feinstein DL; Hidalgo J; Garcia A
    Acta Neuropathol; 2011 Apr; 121(4):499-508. PubMed ID: 21234581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
    Morini M; Roccatagliata L; Dell'Eva R; Pedemonte E; Furlan R; Minghelli S; Giunti D; Pfeffer U; Marchese M; Noonan D; Mancardi G; Albini A; Uccelli A
    J Neuroimmunol; 2004 Mar; 148(1-2):146-53. PubMed ID: 14975595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.